(1) Single-gene testing was used in a selected group of SCA (owing to a strong clinical suspicion or, particularly for MJD/SCA3, its high prevalence in our country), with a detection rate of 76.9%; the remaining probands, followed established diagnostic recommendations [25]. The gene discussed is ATXN3; the disease is Machado-Joseph disease.